---
title: "Neutra Corp. files Form 15 to end SEC reporting duties"
url: "https://aibio.space/news/neutra-corp-files-form-15-end-sec-reporting-duties/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2024-12-12"
section: "Listings"
tickers: "OTC:NTRR"
source: "https://www.sec.gov/Archives/edgar/data/1512886/000116169724000513/form_15.htm"
summary: "The notice, dated December 11, 2024, lists 16 holders of record of its common stock."
---

By the aibio.space news desk.

Sources

- [Neutra Corp. 15-12G (2024-12-12)](https://www.sec.gov/Archives/edgar/data/1512886/000116169724000513/form_15.htm)

[NTRR](https://aibio.space/companies/neutra/)

2024-12-12

# Neutra Corp. files Form 15 to end SEC reporting duties

Tickers [NTRR](https://aibio.space/companies/neutra/)

The notice, dated December 11, 2024, lists 16 holders of record of its common stock.

## Key facts

- **Company**: Neutra Corp. (OTC: NTRR)

- **News type**: Listings

- **Primary source**: [Neutra Corp. 15-12G (2024-12-12)](https://www.sec.gov/Archives/edgar/data/1512886/000116169724000513/form_15.htm)

*The Washington Monument and the city beyond. Photo: Carol M Highsmith, CC0, via rawpixel. The picture shows the field, not the companies named.*

Neutra Corp. filed a Form 15 with the Securities and Exchange Commission, dated December 11, 2024. Form 15 is a certification and notice of termination of registration of a class of securities, or suspension of the duty to file reports under the Securities Exchange Act of 1934.

The filing covers the company's common stock. The company marked Rule 12g-4(a)(1) and Rule 12g-4(a)(2) as the provisions it relies on to terminate or suspend the duty to file reports.

The notice gives the approximate number of holders of record as of the certification date as 16.

The company's principal executive offices are in Houston, Texas, and its Commission File Number is 0-55077. Once the duty to file reports ends, the company would no longer be required to file periodic reports such as annual and quarterly reports with the SEC.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

NTRR

Neutra Corp.

OTC · United States

Open the starter desk

## More in Listings

Listings

### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/)

Oct 29, 2026

Listings

### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/)

Oct 29, 2026

Listings

### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/)

Oct 28, 2026

---
Source page: https://aibio.space/news/neutra-corp-files-form-15-end-sec-reporting-duties/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Neutra Corp. files Form 15 to end SEC reporting duties", 2024-12-12, https://aibio.space/news/neutra-corp-files-form-15-end-sec-reporting-duties/